Francesco Bellinato

59PUBLICATIONS
164CO-AUTHORS
AllergyInnate immunityPharmaceutical delivery technologiesEpidemiological methodsWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Nov 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno, G Nazzaro, L Argnani

|Nov 15, 2025
Tirzepatide in obese patients with psoriasis on biological therapy: Is this a window of opportunity?

Paolo Gisondi, Noemi Brigenti, Francesco Bellinato

|Nov 15, 2025
Management of IL-17 inhibitors-induced paradoxical eczema in patients with plaque psoriasis.

Paolo Gisondi, Francesco Bellinato

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Sep 27, 2025
Bluish-Green Coloration of the Nipples: A Diagnostic Clue for Retroareolar Cysts.

Tea Curic, Francesco Bellinato, Paolo Gisondi

Pageof 10

Frequent Collaborators

40 joint publications

Paolo Gisondi

35 joint publications

Giampiero Girolomoni

13 joint publications

Martina Maurelli

7 joint publications

Simone Ribero